Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD1433 and Conjunctive Melanoma (CM)

<< Previous

Bullboard Posts

Next >>

Comment by MuskieMan50on Sep 20, 2021 8:46pm

312 Views

Post# 33890671

RE:RE:TLD1433 and Conjunctive Melanoma (CM)

Eog,
Very interesting summation there.It is such a human tragedy that all of these indications are just sitting there idly.I have always felt that the technology deserves to be in hands where there is ample money to futher adavance it.I think there was some kind of a deal in the works.Another poster had suggested this a bit ago.I will find it and bump it up

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec